Syndax Pharmaceuticals: Thesis Firing On All Cylinders, Sales Acceleration In 2026
Source: SeekingAlpha
2025-11-05 11:57:38 ET
Shares of Syndax Pharmaceuticals, Inc. ( SNDX ) are slightly in the green since my August article provided an overview of the company's two drug launches in AML and chronic GVHD....
Read the full article on Seeking Alpha
For further details see:
Syndax Pharmaceuticals: Thesis Firing On All Cylinders, Sales Acceleration In 2026
Syndax Pharmaceuticals Inc.
NASDAQ: SNDX
SNDX Trading
-3.25% G/L:
$23.38 Last:
835,922 Volume:
$24.24 Open:
SNDX Latest News
March 13, 2026 09:29:43 am
Cancer Drug Maker With $172 Million Revenue and Multiple Approved Therapies Draws $6.5 Million Investment
February 26, 2026 04:01:00 pm
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
SNDX Stock Data
$1,884,313,688
83,351,330
1.17%
104
N/A
Biotechnology & Life Sciences
Healthcare
US
NEW YORK
